Press Release

<< Back
Printer Friendly Version View printer-friendly version
Depomed to Present at the Morgan Stanley Global Healthcare Conference

NEWARK, Calif. , Sept. 05, 2017 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that its senior management will participate in a fireside chat at the 2017 Morgan Stanley Global Healthcare Conference scheduled for 4:40 pm ET (1:40 am PT) on Tuesday, September 12, 2017 in New York, New York.

The fireside chat will be webcast live and may be accessed via the Investor Relations page of the Depomed website at www.depomed.com.  A recording of the event will be archived for 30 days on the company's website.

About Depomed

Depomed is a leading specialty pharmaceutical company focused on enhancing the lives of the patients, families, physicians, providers and payors we serve through commercializing innovative products for pain and neurology related disorders. Depomed markets six medicines with areas of focus that include mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain. Depomed is headquartered in Newark, California. To learn more about Depomed, visit www.depomed.com.

Investor and Media Contact:

Christopher Keenan
VP, Investor Relations and Corporate Communications
510-744-8000
ckeenan@depomed.com

Primary Logo

Depomed, Inc